TOP 5 ASX STOCK PICKS FOR 2024
Welcome to the most awaited guide of 2024! With the expert-tested team having crunched the numbers within ASX's market, we have found the best of the opportunities that can be looked at in the coming year.
Veye’s team of research analysts shortlist companies having potentially a faster dividend growth backed by the earnings growth. And combining this with various parameters like dividend history, payout ratio, dividend coverage becomes an embellishment and can help investors in living off dividend incomes.
Since timing is integral to any stock recommendation, Veye has been putting extra emphasis on this and have chosen stocks at the most appropriate time. We recommended some undervalued stocks when the economy was showing early signs of recovery.
Hand-picked ASX stocks by experts
To the point & concise reports on Top ASX stocks
Recommendations by experts with 20+ years of stock market experience on Top ASX stocks
As a long time fan of technical analysis I appreciate that Veye presents this aspect of buying and selling shares in addition to informative financial aspects of individual stocks.
Veye have helped me make considerable gains with my share portfolio. They are good to deal with offer answer to all my questions. Their reports are very helpful in making the right decision.
Good quality research and easy to understand recommendations.
At Veye, we understand that making investment decisions can be a daunting task. That's why we offer comprehensive market research on ASX stocks to help investors navigate the complexities of the market and make informed decisions about buying, selling or holding stocks.
Our team of expert analysts conducts rigorous research and analysis to provide unbiased recommendations on a range of stocks across various industries. Our reports are designed to be accessible to all investors, regardless of their level of experience or financial expertise.
Our research is conducted with a focus on accuracy and objectivity, ensuring that our clients receive the most reliable and trustworthy information possible about individual stocks.
| Code | Avg.Buy Price | Sell Price | Gain/Loss |
|---|---|---|---|
| Race Oncology Limited (RAC) | $0.990 | $1.275 | 28.79% |
| The Star Entertainment Group Ltd (SGR) | $4.80 | $0.505 | -89.48% |
| Hygrovest Limited (HGV) | $0.375 | $0.046 | -87.73% |
| Spartan Resources Limited (SPR) | $0.410 | $0.590 | 43.9% |
| Vulcan Energy Resources Limited (VUL) | $2.575 | $2.55 | -0.97% |
| Westgold Resources Limited (WGX) | $1.756 | $2.36 | 34.4% |
Not every company performs as expected. Past performance is not an indication of future returns. "Gain/Loss" reflects difference in average buy price and sell price plus dividends as a percentage of average buy price, and does not take into account costs or taxation."
Research analysts examine the top-line growth and net earnings growth of ASX companies because they primarily use a top-down methodology. Several other parameters such as: assess revenue-generating assets that may support the generation of free cash flow; take note of the growth in capital expenditures and its right allocation; the relative performance of the assets; debt equity structure of the company, liquidity position, growth rate over past 5 years, and operating cycle etc.
Several companies, including PharmAust Limited (ASX: PAA), Nuix Limited (ASX: NXL), and Dimerix Limited (ASX: DXB), appear to have promising futures based on a review of the company's fundamentals and various recent developments.
We believe that the best ASX shares to consider are PharmAust Limited (ASX: PAA) and Nuix Limited (ASX: NXL). Investors should exercise caution and undertake thorough research prior to making any investments in the following companies, even though these businesses may be able to weather challenges and still perform well. An investor investing in ASX companies will be in charge of their own funds.
Each week we cover a company which offers a good combination of growth and dividends. It’s a key idea in many portfolios to have.. If you have a high-risk appetite, you may prefer to invest in companies that have a scope for high potential returns. After all, t..
In this report we cover low priced stocks chosen after proper screening, which can have the potential.
Each week we cover a company which offers a good combination of growth and dividends. It’s a key idea in many portfolios to have..
Disclaimer
Veye Pty Ltd only provides general, and not personalised financial advice, and has not taken your personal circumstances into account. Veye Pty Ltd operates under AFSL 523157. For more information please see our Financial Services Guide. Please remember that investments can go up and down. Any past performance shown is not an indication of Future Returns. Commission and other costs charged by executing broker are not considered when calculating past performance. We request our readers not to interpret our reports as direct recommendations. Veye Pty Ltd does not guarantee the performance of, or returns on any investment.